Table of Contents
Global Non - insulin Diabetes Therapeutics Sales Market Report 2021
1 Non - insulin Diabetes Therapeutics Market Overview
1.1 Product Overview and Scope of Non - insulin Diabetes Therapeutics
1.2 Classification of Non - insulin Diabetes Therapeutics by Product Category
1.2.1 Global Non - insulin Diabetes Therapeutics Market Size (Sales) Comparison by Type ( 2016 - 2027)
1.2.2 Global Non - insulin Diabetes Therapeutics Market Size (Sales) Market Share by Type (Product Category) in 2020
1.2.3 Alpha - glucosidase Inhibitors
1.2.4 Amylin Agonists
1.2.5 Biguanides
1.2.6 Dipeptidyl Peptidase - 4 (DPP4) Inhibitors
1.2.7 Glinides / Meglitinides
1.2.8 GLP - 1 Analogs / GLP - 1 Agonists
1.2.9 Sodium - glucose Cotransporter 2 (SGLT2) Inhibitors
1.2.10 Sulfonylureas
1.2.11 Thiazolidinediones
1.2.12 Others
1.3 Global Non - insulin Diabetes Therapeutics Market by Application/End Users
1.3.1 Global Non - insulin Diabetes Therapeutics Sales (Volume) and Market Share Comparison by Application ( 2016 - 2027)
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacy
1.3.5 Others
1.4 Global Non - insulin Diabetes Therapeutics Market by Region
1.4.1 Global Non - insulin Diabetes Therapeutics Market Size (Value) Comparison by Region ( 2016 - 2027)
1.4.2 United States Non - insulin Diabetes Therapeutics Status and Prospect ( 2016 - 2027)
1.4.3 China Non - insulin Diabetes Therapeutics Status and Prospect ( 2016 - 2027)
1.4.4 Europe Non - insulin Diabetes Therapeutics Status and Prospect ( 2016 - 2027)
1.4.5 Japan Non - insulin Diabetes Therapeutics Status and Prospect ( 2016 - 2027)
1.4.6 Southeast Asia Non - insulin Diabetes Therapeutics Status and Prospect ( 2016 - 2027)
1.4.7 India Non - insulin Diabetes Therapeutics Status and Prospect ( 2016 - 2027)
1.5 Global Market Size (Value and Volume) of Non - insulin Diabetes Therapeutics ( 2016 - 2027)
1.5.1 Global Non - insulin Diabetes Therapeutics Sales and Growth Rate ( 2016 - 2027)
1.5.2 Global Non - insulin Diabetes Therapeutics Revenue and Growth Rate ( 2016 - 2027)
2 Global Non - insulin Diabetes Therapeutics Competition by Players/Suppliers, Type and Application
2.1 Global Non - insulin Diabetes Therapeutics Market Competition by Players/Suppliers
2.1.1 Global Non - insulin Diabetes Therapeutics Sales and Market Share of Key Players/Suppliers ( 2016 - 2021)
2.1.2 Global Non - insulin Diabetes Therapeutics Revenue and Share by Players/Suppliers ( 2016 - 2021)
2.2 Global Non - insulin Diabetes Therapeutics (Volume and Value) by Type
2.2.1 Global Non - insulin Diabetes Therapeutics Sales and Market Share by Type ( 2016 - 2021)
2.2.2 Global Non - insulin Diabetes Therapeutics Revenue and Market Share by Type ( 2016 - 2021)
2.3 Global Non - insulin Diabetes Therapeutics (Volume and Value) by Region
2.3.1 Global Non - insulin Diabetes Therapeutics Sales and Market Share by Region ( 2016 - 2021)
2.3.2 Global Non - insulin Diabetes Therapeutics Revenue and Market Share by Region ( 2016 - 2021)
2.4 Global Non - insulin Diabetes Therapeutics (Volume) by Application
3 United States Non - insulin Diabetes Therapeutics (Volume, Value and Sales Price)
3.1 United States Non - insulin Diabetes Therapeutics Sales and Value ( 2016 - 2021)
3.1.1 United States Non - insulin Diabetes Therapeutics Sales and Growth Rate ( 2016 - 2021)
3.1.2 United States Non - insulin Diabetes Therapeutics Revenue and Growth Rate ( 2016 - 2021)
3.1.3 United States Non - insulin Diabetes Therapeutics Sales Price Trend ( 2016 - 2021)
3.2 United States Non - insulin Diabetes Therapeutics Sales Volume and Market Share by Players ( 2016 - 2021)
3.3 United States Non - insulin Diabetes Therapeutics Sales Volume and Market Share by Type ( 2016 - 2021)
3.4 United States Non - insulin Diabetes Therapeutics Sales Volume and Market Share by Application ( 2016 - 2021)
4 China Non - insulin Diabetes Therapeutics (Volume, Value and Sales Price)
4.1 China Non - insulin Diabetes Therapeutics Sales and Value ( 2016 - 2021)
4.1.1 China Non - insulin Diabetes Therapeutics Sales and Growth Rate ( 2016 - 2021)
4.1.2 China Non - insulin Diabetes Therapeutics Revenue and Growth Rate ( 2016 - 2021)
4.1.3 China Non - insulin Diabetes Therapeutics Sales Price Trend ( 2016 - 2021)
4.2 China Non - insulin Diabetes Therapeutics Sales Volume and Market Share by Players ( 2016 - 2021)
4.3 China Non - insulin Diabetes Therapeutics Sales Volume and Market Share by Type ( 2016 - 2021)
4.4 China Non - insulin Diabetes Therapeutics Sales Volume and Market Share by Application ( 2016 - 2021)
5 Europe Non - insulin Diabetes Therapeutics (Volume, Value and Sales Price)
5.1 Europe Non - insulin Diabetes Therapeutics Sales and Value ( 2016 - 2021)
5.1.1 Europe Non - insulin Diabetes Therapeutics Sales and Growth Rate ( 2016 - 2021)
5.1.2 Europe Non - insulin Diabetes Therapeutics Revenue and Growth Rate ( 2016 - 2021)
5.1.3 Europe Non - insulin Diabetes Therapeutics Sales Price Trend ( 2016 - 2021)
5.2 Europe Non - insulin Diabetes Therapeutics Sales Volume and Market Share by Players ( 2016 - 2021)
5.3 Europe Non - insulin Diabetes Therapeutics Sales Volume and Market Share by Type ( 2016 - 2021)
5.4 Europe Non - insulin Diabetes Therapeutics Sales Volume and Market Share by Application ( 2016 - 2021)
6 Japan Non - insulin Diabetes Therapeutics (Volume, Value and Sales Price)
6.1 Japan Non - insulin Diabetes Therapeutics Sales and Value ( 2016 - 2021)
6.1.1 Japan Non - insulin Diabetes Therapeutics Sales and Growth Rate ( 2016 - 2021)
6.1.2 Japan Non - insulin Diabetes Therapeutics Revenue and Growth Rate ( 2016 - 2021)
6.1.3 Japan Non - insulin Diabetes Therapeutics Sales Price Trend ( 2016 - 2021)
6.2 Japan Non - insulin Diabetes Therapeutics Sales Volume and Market Share by Players ( 2016 - 2021)
6.3 Japan Non - insulin Diabetes Therapeutics Sales Volume and Market Share by Type ( 2016 - 2021)
6.4 Japan Non - insulin Diabetes Therapeutics Sales Volume and Market Share by Application ( 2016 - 2021)
7 Southeast Asia Non - insulin Diabetes Therapeutics (Volume, Value and Sales Price)
7.1 Southeast Asia Non - insulin Diabetes Therapeutics Sales and Value ( 2016 - 2021)
7.1.1 Southeast Asia Non - insulin Diabetes Therapeutics Sales and Growth Rate ( 2016 - 2021)
7.1.2 Southeast Asia Non - insulin Diabetes Therapeutics Revenue and Growth Rate ( 2016 - 2021)
7.1.3 Southeast Asia Non - insulin Diabetes Therapeutics Sales Price Trend ( 2016 - 2021)
7.2 Southeast Asia Non - insulin Diabetes Therapeutics Sales Volume and Market Share by Players ( 2016 - 2021)
7.3 Southeast Asia Non - insulin Diabetes Therapeutics Sales Volume and Market Share by Type ( 2016 - 2021)
7.4 Southeast Asia Non - insulin Diabetes Therapeutics Sales Volume and Market Share by Application ( 2016 - 2021)
8 India Non - insulin Diabetes Therapeutics (Volume, Value and Sales Price)
8.1 India Non - insulin Diabetes Therapeutics Sales and Value ( 2016 - 2021)
8.1.1 India Non - insulin Diabetes Therapeutics Sales and Growth Rate ( 2016 - 2021)
8.1.2 India Non - insulin Diabetes Therapeutics Revenue and Growth Rate ( 2016 - 2021)
8.1.3 India Non - insulin Diabetes Therapeutics Sales Price Trend ( 2016 - 2021)
8.2 India Non - insulin Diabetes Therapeutics Sales Volume and Market Share by Players ( 2016 - 2021)
8.3 India Non - insulin Diabetes Therapeutics Sales Volume and Market Share by Type ( 2016 - 2021)
8.4 India Non - insulin Diabetes Therapeutics Sales Volume and Market Share by Application ( 2016 - 2021)
9 Global Non - insulin Diabetes Therapeutics Players/Suppliers Profiles and Sales Data
9.1 GSK
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Non - insulin Diabetes Therapeutics Product Category, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 GSK Non - insulin Diabetes Therapeutics Sales, Revenue, Price and Gross Margin ( 2016 - 2021)
9.1.4 Main Business/Business Overview
9.2 Eli Lilly
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Non - insulin Diabetes Therapeutics Product Category, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 Eli Lilly Non - insulin Diabetes Therapeutics Sales, Revenue, Price and Gross Margin ( 2016 - 2021)
9.2.4 Main Business/Business Overview
9.3 Sumitomo Dainippon Pharma
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Non - insulin Diabetes Therapeutics Product Category, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 Sumitomo Dainippon Pharma Non - insulin Diabetes Therapeutics Sales, Revenue, Price and Gross Margin ( 2016 - 2021)
9.3.4 Main Business/Business Overview
9.4 Intarcia Therapeutics
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Non - insulin Diabetes Therapeutics Product Category, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 Intarcia Therapeutics Non - insulin Diabetes Therapeutics Sales, Revenue, Price and Gross Margin ( 2016 - 2021)
9.4.4 Main Business/Business Overview
9.5 Servier
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Non - insulin Diabetes Therapeutics Product Category, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 Servier Non - insulin Diabetes Therapeutics Sales, Revenue, Price and Gross Margin ( 2016 - 2021)
9.5.4 Main Business/Business Overview
9.6 Jiangsu Hansoh Pharmaceutical
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Non - insulin Diabetes Therapeutics Product Category, Application and Specification
9.6.2.1 Product A
9.6.2.2 Product B
9.6.3 Jiangsu Hansoh Pharmaceutical Non - insulin Diabetes Therapeutics Sales, Revenue, Price and Gross Margin ( 2016 - 2021)
9.6.4 Main Business/Business Overview
9.7 Novo Nordisk
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Non - insulin Diabetes Therapeutics Product Category, Application and Specification
9.7.2.1 Product A
9.7.2.2 Product B
9.7.3 Novo Nordisk Non - insulin Diabetes Therapeutics Sales, Revenue, Price and Gross Margin ( 2016 - 2021)
9.7.4 Main Business/Business Overview
9.8 Emisphere
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Non - insulin Diabetes Therapeutics Product Category, Application and Specification
9.8.2.1 Product A
9.8.2.2 Product B
9.8.3 Emisphere Non - insulin Diabetes Therapeutics Sales, Revenue, Price and Gross Margin ( 2016 - 2021)
9.8.4 Main Business/Business Overview
9.9 Uni - Bio Science Group
9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2 Non - insulin Diabetes Therapeutics Product Category, Application and Specification
9.9.2.1 Product A
9.9.2.2 Product B
9.9.3 Uni - Bio Science Group Non - insulin Diabetes Therapeutics Sales, Revenue, Price and Gross Margin ( 2016 - 2021)
9.9.4 Main Business/Business Overview
9.10 Takeda
9.10.1 Company Basic Information, Manufacturing Base and Competitors
9.10.2 Non - insulin Diabetes Therapeutics Product Category, Application and Specification
9.10.2.1 Product A
9.10.2.2 Product B
9.10.3 Takeda Non - insulin Diabetes Therapeutics Sales, Revenue, Price and Gross Margin ( 2016 - 2021)
9.10.4 Main Business/Business Overview
9.11 3SBio
9.12 Merck
9.13 Dong - A Pharmaceutical
9.14 Luye Pharma Group
9.15 Eurofarma
9.16 Geropharm
9.17 Alkem Labs
9.18 SatRx
9.19 Pfizer
9.20 Jiangsu Hengrui Medicine
10 Non - insulin Diabetes Therapeutics Maufacturing Cost Analysis
10.1 Non - insulin Diabetes Therapeutics Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Non - insulin Diabetes Therapeutics
10.3 Manufacturing Process Analysis of Non - insulin Diabetes Therapeutics
11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Non - insulin Diabetes Therapeutics Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Non - insulin Diabetes Therapeutics Major Manufacturers in 2020
11.4 Downstream Buyers
12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List
13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change
14 Global Non - insulin Diabetes Therapeutics Market Forecast ( 2021 - 2027)
14.1 Global Non - insulin Diabetes Therapeutics Sales Volume, Revenue and Price Forecast ( 2021 - 2027)
14.1.1 Global Non - insulin Diabetes Therapeutics Sales Volume and Growth Rate Forecast ( 2021 - 2027)
14.1.2 Global Non - insulin Diabetes Therapeutics Revenue and Growth Rate Forecast ( 2021 - 2027)
14.1.3 Global Non - insulin Diabetes Therapeutics Price and Trend Forecast ( 2021 - 2027)
14.2 Global Non - insulin Diabetes Therapeutics Sales Volume, Revenue and Growth Rate Forecast by Region ( 2021 - 2027)
14.2.1 Global Non - insulin Diabetes Therapeutics Sales Volume and Growth Rate Forecast by Regions ( 2021 - 2027)
14.2.2 Global Non - insulin Diabetes Therapeutics Revenue and Growth Rate Forecast by Regions ( 2021 - 2027)
14.2.3 United States Non - insulin Diabetes Therapeutics Sales Volume, Revenue and Growth Rate Forecast ( 2021 - 2027)
14.2.4 China Non - insulin Diabetes Therapeutics Sales Volume, Revenue and Growth Rate Forecast ( 2021 - 2027)
14.2.5 Europe Non - insulin Diabetes Therapeutics Sales Volume, Revenue and Growth Rate Forecast ( 2021 - 2027)
14.2.6 Japan Non - insulin Diabetes Therapeutics Sales Volume, Revenue and Growth Rate Forecast ( 2021 - 2027)
14.2.7 Southeast Asia Non - insulin Diabetes Therapeutics Sales Volume, Revenue and Growth Rate Forecast ( 2021 - 2027)
14.2.8 India Non - insulin Diabetes Therapeutics Sales Volume, Revenue and Growth Rate Forecast ( 2021 - 2027)
14.3 Global Non - insulin Diabetes Therapeutics Sales Volume, Revenue and Price Forecast by Type ( 2021 - 2027)
14.3.1 Global Non - insulin Diabetes Therapeutics Sales Forecast by Type ( 2021 - 2027)
14.3.2 Global Non - insulin Diabetes Therapeutics Revenue Forecast by Type ( 2021 - 2027)
14.3.3 Global Non - insulin Diabetes Therapeutics Price Forecast by Type ( 2021 - 2027)
14.4 Global Non - insulin Diabetes Therapeutics Sales Volume Forecast by Application ( 2021 - 2027)
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Disclaimer
List of Tables and Figures
Figure Product Picture of Non - insulin Diabetes Therapeutics
Figure Global Non - insulin Diabetes Therapeutics Sales Volume Comparison (K Units) by Type ( 2016 - 2027)
Figure Global Non - insulin Diabetes Therapeutics Sales Volume Market Share by Type (Product Category) in 2020
Figure Alpha - glucosidase Inhibitors Product Picture
Figure Amylin Agonists Product Picture
Figure Biguanides Product Picture
Figure Dipeptidyl Peptidase - 4 (DPP4) Inhibitors Product Picture
Figure Glinides / Meglitinides Product Picture
Figure GLP - 1 Analogs / GLP - 1 Agonists Product Picture
Figure Sodium - glucose Cotransporter 2 (SGLT2) Inhibitors Product Picture
Figure Sulfonylureas Product Picture
Figure Thiazolidinediones Product Picture
Figure Others Product Picture
Figure Global Non - insulin Diabetes Therapeutics Sales Comparison (K Units) by Application ( 2016 - 2027)
Figure Global Sales Market Share of Non - insulin Diabetes Therapeutics by Application in 2020
Figure Hospital Pharmacy Examples
Table Key Downstream Customer in Hospital Pharmacy
Figure Retail Pharmacies Examples
Table Key Downstream Customer in Retail Pharmacies
Figure Online Pharmacy Examples
Table Key Downstream Customer in Online Pharmacy
Figure Others Examples
Table Key Downstream Customer in Others
Figure Global Non - insulin Diabetes Therapeutics Market Size (Million USD) by Regions ( 2016 - 2027)
Figure United States Non - insulin Diabetes Therapeutics Revenue (Million USD) and Growth Rate ( 2016 - 2027)
Figure China Non - insulin Diabetes Therapeutics Revenue (Million USD) and Growth Rate ( 2016 - 2027)
Figure Europe Non - insulin Diabetes Therapeutics Revenue (Million USD) and Growth Rate ( 2016 - 2027)
Figure Japan Non - insulin Diabetes Therapeutics Revenue (Million USD) and Growth Rate ( 2016 - 2027)
Figure Southeast Asia Non - insulin Diabetes Therapeutics Revenue (Million USD) and Growth Rate ( 2016 - 2027)
Figure India Non - insulin Diabetes Therapeutics Revenue (Million USD) and Growth Rate ( 2016 - 2027)
Figure Global Non - insulin Diabetes Therapeutics Sales Volume (K Units) and Growth Rate ( 2016 - 2027)
Figure Global Non - insulin Diabetes Therapeutics Revenue (Million USD) and Growth Rate ( 2016 - 2027)
Figure Global Market Major Players Non - insulin Diabetes Therapeutics Sales Volume (K Units) ( 2016 - 2021)
Table Global Non - insulin Diabetes Therapeutics Sales (K Units) of Key Players/Suppliers ( 2016 - 2021)
Table Global Non - insulin Diabetes Therapeutics Sales Share by Players/Suppliers ( 2016 - 2021)
Figure 2020 Non - insulin Diabetes Therapeutics Sales Share by Players/Suppliers
Figure 2020 Non - insulin Diabetes Therapeutics Sales Share by Players/Suppliers
Figure Global Non - insulin Diabetes Therapeutics Revenue (Million USD) by Players/Suppliers ( 2016 - 2021)
Table Global Non - insulin Diabetes Therapeutics Revenue (Million USD) by Players/Suppliers ( 2016 - 2021)
Table Global Non - insulin Diabetes Therapeutics Revenue Share by Players/Suppliers ( 2016 - 2021)
Table 2020 Global Non - insulin Diabetes Therapeutics Revenue Share by Players
Table 2020 Global Non - insulin Diabetes Therapeutics Revenue Share by Players
Table Global Non - insulin Diabetes Therapeutics Sales (K Units) and Market Share by Type ( 2016 - 2021)
Table Global Non - insulin Diabetes Therapeutics Sales Share (K Units) by Type ( 2016 - 2021)
Figure Sales Market Share of Non - insulin Diabetes Therapeutics by Type ( 2016 - 2021)
Figure Global Non - insulin Diabetes Therapeutics Sales Growth Rate by Type ( 2016 - 2021)
Table Global Non - insulin Diabetes Therapeutics Revenue (Million USD) and Market Share by Type ( 2016 - 2021)
Table Global Non - insulin Diabetes Therapeutics Revenue Share by Type ( 2016 - 2021)
Figure Revenue Market Share of Non - insulin Diabetes Therapeutics by Type ( 2016 - 2021)
Figure Global Non - insulin Diabetes Therapeutics Revenue Growth Rate by Type ( 2016 - 2021)
Table Global Non - insulin Diabet
